focusIR Fundamentals: GenIP's Invention Evaluator: combining AI with human expertise

GenIP plc is moving to commercialise its Invention Evaluator platform designed to help organisations identify which inventions have the greatest potential to reach the market. Cur ...
London South East

Celebrus Tech Share Chat (CLBS)

London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as ...

BoE looks into claim Barclays private credit exposure misrepresented, FT reports

PRA received complaint after ​insider raised concerns, FT reports * Barclays says it takes regulatory obligations seriously * Barclays shares down 2.6%. Oct ​19 (Reuters) - ...

Tek 4 targets GBP42 million valuation in London AIM flotation

(Alliance News) - Tek 4 Holdco Ltd on Monday said it plans to raise GBP2.0 million through an initial public offering on London's AIM market next week, targeting a market capitalisation of GBP42.0 ...

GSK's Ris‑Rez shows 61pc response rate in early lung cancer study

In a phase Ib study, GSK said the drug produced a 61% response rate at the higher 8mg/kg dose, compared with 32% at 6mg/kg. GSK said the results, which will be presented at the ESMO 2026 congress in ...

FOCUS-Cherry or tabasco? Perfumers test weight-loss drug users' appetite for food-inspired scents

FOCUS-Cherry or tabasco? Perfumers test weight-loss drug users' appetite for food-inspired scents | Financial News ...

PRESS: BoE probes Barclays over private credit exposure claims - FT

The Bank of England is examining whether traders at Barclays PLC misrepresented illiquid private credit loans to understate their risk after concerns were raised by an insider, the Financial Times ...

Volex expects top-end operating profit after "excellent" first half

Volex PLC on Monday forecast first-half revenue growth of around 22%, although it cautioned that headline year-on-year growth rates have started to "normalise". The Hampshire, England-based maker of ...

GSK lung cancer treatment data shows "positive anti-tumour activity"

GSK PLC on Monday set out its first batch of global data for the risvutatug rezetecan drug. The London-based biopharmaceutical and biotechnology company said the drug would help patients with advanced ...

London open: Stocks fall as investors eye US tech earnings

London stocks fell in early trade on Monday as investors mulled a raft of Chinese data and looked ahead to the release of key US tech earnings this week. At 0840 BST, the FTSE 100 was down 0.6% at 10, ...

Mulberry H1 sales rise 18% as turnaround takes shape

Mulberry reported a jump in first-half sales on Monday as it said its turnaround was taking shape, highlighting strong full-price sales growth and a solid performance in the US. In the 26 weeks to 26 ...

LondonMetric rental income rises 8% as property portfolio grows

LondonMetric Property PLC on Monday reported strong rental income growth in the first half of its financial year, supported by acquisitions and leasing activity, as it reaffirmed its confidence in ...